Theflyonthewall.com is Wall Street's specialist in breaking equity news. Veteran traders build a proprietary feed of news that's faster and more relevant than any other source. Try us for free and discover for yourself.
Theflyonthewall.com is Wall Street's specialist in breaking equity news. Veteran traders build a proprietary feed of news that's faster and more relevant than any other source. Try us for free and discover for yourself.
Below are some Regulatory Catalyst Index updates for companies with recent FDA and clinical trial related news…
On 7/20/10, MannKind (NASDAQ:MNKD) announced that the FDA accepted its New Drug Application (NDA) resubmission for AFREZZA (orally ...
Related Articls:
Stephen Bernard, AP Business Writer Stocks mixed as caution about recovery remains Stocks mixed even as claims for unemployment benefits fall more than expected NEW YORK (AP) — Major stock indexes turned mixed Thursday as a drop in new claims for unemployment benefits wasn’t enough to resolve worries about the economy. The Dow Jones industrial [...]
By Leah Schnurr – Reuters Stocks hit lowest level in seven weeks NEW YORK (Reuters) – Stocks fell to their lowest level in seven weeks on Tuesday as an unexpectedly large drop in home sales ratcheted up concerns that the economic recovery is even weaker than had been feared. The Dow and S&P 500 racked [...]
Below are some Regulatory Catalyst Index updates for companies with recent FDA and clinical trial related news…
On 7/20/10, MannKind (NASDAQ:MNKD) announced that the FDA accepted its New Drug Application (NDA) resubmission for AFREZZA (orally ...
Related Articls:
